Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 27, 2017
Pharmacy Choice - News - Front Page Healthcare News - May 27, 2017

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

5/27/17 - "Combination Pharmaceutical Composition and Methods of Treating Diseases Or Conditions Associated with Neurodegenerative Diseases" in Patent...
"Combination Pharmaceutical Composition and Methods of Treating Diseases Or Conditions Associated with Neurodegenerative Diseases" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventor Epshtein, Oleg Iliich, filed on January 3, 2017, was made available
5/27/17 - "Method for Preparing Azetidinone Compound and Intermediate of Azetidinone Compound" in Patent Application Approval Process (USPTO 20170121281)
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventors BAI, Hua; ZHAO, Xuyang; ZHANG, Yuncai; LI, Xufei; ZHANG, Yong; XU, Dezhou; ZHANG, Li; XU, Xiaojie; ZHU, Qifeng; WANG, Xiaoming; YANG, Zhiqing; ZHONG, Zehua; ZHANG, Jian, filed on June 5, 2015, was made available online on May 11, 2017, ac
5/27/17 - Abide Therapeutics Announces Dosing of First Subject in fMRI Imaging Study to Investigate Brain Activity Patterns Associated with ABX-1431
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Abide Therapeutics, a developer of innovative pharmaceuticals, announced initiation of dosing in a Phase 1 study using functional magnetic resonance imaging to evaluate patterns of neural activity in the brain associated with oral administration of ABX-1431, a first-in-class.
5/27/17 - Analysis of the Congressional Budget Office's Estimate of the House-Passed Affordable Care Act Repeal Legislation
The AHCA would benefit wealthy households and insurance and drug companies at the expense of low and moderate-income individuals who would be harmed by radical cuts to Medicaid and much reduced premium tax credits to purchase health care in the Affordable Care Act's marketplaces. CBO/JCT project that losses will occur due to the proposal's repeal o
5/27/17 - Cancer scientist tries to help others as he battles his own Stage 4 cancer [The San Diego Union-Tribune]
The lanky, low-key and bearded Point Loma Heights resident has a doctorate in medicinal chemistry and is the co-inventor of Zykadia, an FDA- approved lung cancer drug made by his employer, the massive Switzerland- based pharmaceutical company, Novartis. Four years later, that personal project, with the help of the advocacy group Fight Colorectal Ca
5/27/17 - Challenging year as waits have increased
The Shrewsbury and Telford Hospital NHS Trust annual report gives an insight into the challenges experienced by the hospitals between March 2016 and March this year. About 80 per cent of A&E patients were admitted or discharged within four hours at Royal Shrewsbury Hospital and Telford's Princess Royal. Infections Simon Wright, chief executive of t
5/27/17 - EDITORIAL: Hastening Obamacare's demise isn't a solution [The Kansas City Star]
May 27 Now that our area's top insurer, Blue Cross and Blue Shield of Kansas City, has announced that it is pulling out of the Affordable Care Act exchange next year, about 67,000 of its customers in Kansas and Missouri are vulnerable. Congressional Republicans insist that they don't want insurance markets here or anywhere else to fail. Roy Blunt
5/27/17 - Mast defends House Republicans' overhaul of Affordable Care Act
Brian Mast said Friday that House Republicans' health care overhaul is a "good bill," despite a report that the number of uninsured people would rise to 23 million in the next decade. He said the bulk of the 23 million the Congressional Budget Office estimated this week to be uninsured by 2026 would opt out of coverage because the penalty for not h
5/27/17 - McConnell May Have Been Right: It May Be Too Hard to Replace Obamacare
The many meetings Republicans held to discuss a Senate health care bill have exposed deep fissures within the party that are almost as large as the differences between Republicans and Democrats. He can afford to lose only two Republicans if he is to get a bill through the Senate, and that would require the help of Vice President Mike Pence, who wou
5/27/17 - Researchers Submit Patent Application, "Dengue Virus Specific Multiple HLA Binding T Cell Epitopes for the Use of Universal Vaccine Development", for...
Researchers Submit Patent Application, "Dengue Virus Specific Multiple HLA Binding T Cell Epitopes for the Use of Universal Vaccine Development", for Approval. By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week From Washington, D.C., NewsRx journalists report that a patent application by the inventor Philip, Ramila, filed on
5/27/17 - Sen. Cassidy Explains Plan to Maintain Health Coverage and Lower Premiums
Bill Cassidy, R- La., issued the following news release:. Last night, US Senator Bill Cassidy, MD spoke on the Senate floor to explain provisions in Cassidy-Collins, his Obamacare replacement plan, that would maintain and expand health care coverage and bring down premiums. We are using something which is already used in Medicare and 401 plans and
5/27/17 - Sen. Sanders Statement on Release of CBO Score of Republican Health Care Bill
Bernie Sanders, I-Vt., issued the following news release:. Bernie Sanders made the following statement at a press conference Wednesday after the Congressional Budget Office released its score of the American Health Care Act:. "It's not a health care bill when you cut Medicaid by $800 billion, denying health insurance to children or some of the poo
5/27/17 - Sen. Sanders: Trump's Budget and GOP Healthcare Bill Would Harm Vermonters
Bernie Sanders, who is the ranking member of the Senate Budget Committee and a member of the Senate health committee, detailed the harm President Donald Trump's budget and the Republicans' "health care" legislation would have on Vermonters. *Eliminate health insurance for 100,000 Vermonters by cutting Medicaid by 47 percent by the end of the decade
5/27/17 - Supply, Installation, Commissioning, Personnel Training And Warranty Service Of Medical Equipment For The Department Of Hemodialysis In The Hospital Dr. Atanas Dafovski Sa-. Kardzhali. [TendersInfo (India)]
Contract notice: "supply, installation, commissioning, personnel training and warranty service of medical equipment for the department of hemodialysis in the hospital" dr. atanas dafovski "sa-. kardzhali." The selected contractor delivers, installs, install, test and commissioning six the number of hemodialysis machines. Time limit for receipt of t
5/26/17 - "A Therapeutic Protocol for Treating Ovarian Cancer" in Patent Application Approval Process (USPTO 20170119727)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors Kremmidiotis, Gabriel; BIBBY, David C.; RISCHIN, Danny, filed on May 30, 2014, was made available online on May 11, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Bionomics
5/26/17 - "Extended-Release Topiramate Capsules" in Patent Application Approval Process (USPTO 20170119808)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors BETTERMAN, Sarah Michelle; TANTRY, Jaidev Srinivas; PATRICK, Laura Marie, filed on November 21, 2016, was made available online on May 11, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is
5/26/17 - "SELF-EMULSIFYING COMPOSITION OF W3 FATTY ACID" in Patent Application Approval Process (USPTO 20170119724)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors FUJII, Hirosato; YAMAGATA, Motoo, filed on January 18, 2017, was made available online on May 11, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Mochida Pharmaceutical Co.,
5/26/17 - 2:18 PM To: SCHUMER-PRESS@LISTS.SENATE.GOV
"Nearly two million veteransthat's one in 10 rely on Medicaid for their health care. The Republican plan to dismantle the Affordable Care Act cuts more than $800 billion from Medicaid. At best, this would significantly scale back our veterans' Medicaid benefits and, at worst, cause them to lose their benefits altogether. "
5/26/17 - Abbott Labs: A genomic disease management company, engages in the development and marketing of clinical laboratory products, which provide information critical to the evaluation and management of cancer, prenatal disorders, and other genetic diseases
It currently markets seven U.S. Food and Drug Administration or foreign cleared or approved clinical products in addition to distributing over 300 Analyte Specific Reagent and research products through its direct sales operations in the United States and Europe and a worldwide distribution network covering 59 countries. Mary Szela joined Melinta...
5/26/17 - Abeona Therapeutics receives FDA orphan designation for gene therapy
The FDA has granted Orphan Drug Designation for Abeona Therapeutics's EB-101 gene therapy program for patients with dystrophic epidermolysis bullosa...
5/26/17 - Abeona Therapeutics Receives FDA Orphan Drug Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis Bullosa [Tehran Times (Iran)]
Abeona Therapeutics Inc., a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare diseases, announced today that the FDA has granted Orphan Drug Designation for Abeonas EB-101 gene therapy program for patients with dystrophic epidermolysis bullosa, including recessive dystrophic...
5/26/17 - Active Pharmaceutical Ingredients Market Outlook and Worldwide Forecast to 2027
Global Active Pharmaceutical Ingredients Information, by types, by applications, by manufacturing method-Forecast 2027 Pune, India 05/26/2017 Market Synopsis of Active pharmaceutical ingredients Market:. Active Pharmaceutical Ingredient is the integral part of the drug because of which the disease gets cured. Request a Sample Report@...
5/26/17 - AERI Is Awesome, GWPH Abuzz, FDA Panel Nod For PBYI [Sport360]
Today`s Daily Dose brings you news about Aerie Pharma`s positive efficacy results from phase III study of its glaucoma drug candidate Roclatan; Alnylam`s public offering and FDA panel`s support for approval of Puma`s breast cancer drug Neratinib. Shares of Aerie Pharmaceuticals Inc. climbed more than 27% in extended trading on Wednesday, following.
5/26/17 - Agency Information Collection Activities: Proposed Collection; Comment Request; Applications for Food and Drug Administration Approval To Market a...
SUMMARY: The Food and Drug Administration is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995, Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed...
5/26/17 - American Discount Pharmacy Corp./ UPS: Has been featured on Fox and Wink TV for having some of the best prices on FDA-approved and USA Wholesaler medications
American Discount Pharmacy Corp./ UPS. American Discount Pharmacy has been featured on Fox and Wink TV for having some of the best prices on FDA- approved and USA Wholesaler medications. Their is a prototype UPS located within the store of American Discount Pharmacy Corp./ UPS and we are proud to be a part of this unique combination.
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415